Dynabeads™ Regulatory CD4+/CD25+ T Cell Kit
Dynabeads™ Regulatory CD4+/CD25+ T Cell Kit
Invitrogen™

Dynabeads™ Regulatory CD4+/CD25+ T Cell Kit

Verwenden Sie das Kit, um hochreine regulatorische CD4+-CD25+-T-Zellen (Treg) zu isolieren, die den intrazellulären Transkriptionsfaktor Foxp3 exprimieren. Die Zellfraktion CD4+Weitere Informationen
Have Questions?
KatalognummerMenge
11363D2 x 5 ml
Katalognummer 11363D
Preis (EUR)
1.396,00
Each
Zum Warenkorb hinzufügen
Menge:
2 x 5 ml
Preis (EUR)
1.396,00
Each
Zum Warenkorb hinzufügen
Verwenden Sie das Kit, um hochreine regulatorische CD4+-CD25+-T-Zellen (Treg) zu isolieren, die den intrazellulären Transkriptionsfaktor Foxp3 exprimieren. Die Zellfraktion CD4+ CD25- kann als Effektorzellen in inhibitorischen Folgeassays verwendet werden. Sie können mit > 95 % Reinheit (CD4+ CD25+ Expression) und > 80 % Foxp3-Expression rechnen.

Isolieren Sie bead- und antikörperfreie humane CD4+ CD25+ Foxp3+ Treg-Zellen

Treg-Zellen können mit Dynabeads™ CD3/CD28 Treg-Expander erweitert werden und bleiben
Foxp3+.

Treg-Zellen können in allen nachfolgenden Anwendungen (z. B. Suppression-Assays) verwendet werden.

Methodik:

Das Isolierungsverfahren umfasst die folgenden Schritte:

• Negativisolierung unveränderter menschlicher CD4+-T-Zellen aus PBMC
• Positivisolierung von CD25+-T-Zellen aus der Untergruppe der unveränderten CD4+-T-Zellen
• Entfernung von Beads von den CD4+-CD25+-Treg-Zellen mit DETACHaBEAD™.

Ausgangsprobe: PBMC
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
ZelltypT-Zellen (regulatorisch)
IsolierungstechnikDepletion, dann Positivisolierung
Anzahl ZellenZur Verarbeitung von insgesamt ∼1 x 10^9 Zellen
Ausgabegrad>95 %
ProduktlinieDETACHaBEAD, DYNAL, Dynabeads, FlowComp
Reinheits- oder QualitätsgradForschungsqualität
Menge2 x 5 ml
ProbentypPBMC
VersandbedingungRaumtemperatur
Ausgangsmaterial (Zellzahl)1 x 10^8 PBMCs pro Isolierung
ZielspeziesHuman
ProdukttypKit für die Isolierung von Zellen
Unit SizeEach
Inhalt und Lagerung
Jedes Kit enthält 2 ml Antikörper-Mix Human CD4, 10 ml Depletion MyOne™ Dynabeads™, 5 ml Dynabeads™ CD25 und 2 ml DETACHaBEAD™. Diese Reagenzien reichen zur Verarbeitung von ∼ 1 × 109 Zellen. Lagern Sie die Komponenten bei 2 bis 8 °C.

Häufig gestellte Fragen (FAQ)

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Zitierungen und Referenzen (6)

Zitierungen und Referenzen
Abstract
CD26: a negative selection marker for human Treg cells.
Authors:Salgado FJ, Pérez-Díaz A, Villanueva NM, Lamas O, Arias P, Nogueira M,
Journal:Cytometry A
PubMed ID:22949266
'A major obstacle hampering the therapeutic application of regulatory T (Treg) cells is the lack of suitable extracellular markers, which complicates their identification/isolation. Treg cells are normally isolated via CD25 (IL-2Ra) targeting, but this protein is also expressed by activated CD4(+) effector T (Teff) lymphocytes. Other extracellular (positive or negative) ... More
BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.
Authors:Chaiyachati BH, Jani A, Wan Y, Huang H, Flavell R, Chi T,
Journal:EMBO J
PubMed ID:23321680
'Treg activation in response to environmental cues is necessary for regulatory T cells (Tregs) to suppress inflammation, but little is known about the transcription mechanisms controlling Treg activation. We report that despite the known proinflammatory role of the chromatin-remodelling factor BRG1 in CD4 cells, deleting Brg1 in all aß T ... More
PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells.
Authors:Liu X, Xu X, Lin X, Tian Y, Ji B, Xia S, Xu S, Yin Q, Zhang M, Jiao Z, Wang S, Xu H, Shao Q,
Journal:J Cell Biochem
PubMed ID:22806628
Regulatory T cells (Tregs) are critical for maintaining self-tolerance and homeostasis, and have potential application in clinical disease therapy, such as autoimmune diseases and transplant rejection, but their numbers are limited. FOXP3 is a key transcription factor controlling Tregs development and function. Although transfection of CD4(+)CD25(-) lymphocytes with the FOXP3 ... More
Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
Authors:Namdar A, Nikbin B, Ghabaee M, Bayati A, Izad M,
Journal:J Neuroimmunol
PubMed ID:19932513
Interferon-beta (IFN-beta) is an immunomodulatory drug of choice to control relapsing-remitting multiple sclerosis (RR-MS), although its function is still unclear. A reduced suppressive function of CD4(+)CD25(+) regulatory T cells (T(reg)) has been shown in RR-MS patients. In this study, to understand the effect of IFN-ss on CD4(+)CD25(+) regulatory T cells, ... More
An optimized method for the functional analysis of human regulatory T cells.
Authors:Oberg HH, Wesch D, Lenke J, Kabelitz D,
Journal:Scand J Immunol
PubMed ID:16918705
Naturally occurring regulatory T cells (Treg) suppress the activation of antigen-responsive T cells in a cell contact-dependent manner. In order to investigate the impact of soluble mediators and receptor-ligand interactions on the interplay between naive T cells and Treg, a reproducible suppressor cell assay which functions in the absence of ... More